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Abstract 
Aims: The overall aim of the thesis was to investigate antihypertensive treatment in women and men. 
First, the aim was to analyze the scientific support for treatment recommendations in women and men. 
Second, the aims were to study achieved blood pressure levels and evaluate differences in 
antihypertensive treatment in women and men with new-onset and current hypertension and further to 
study if guidelines were pursued. Finally, the aims were to study the influence of comorbidities and 
psychosocial factors on antihypertensive treatment and achieved target blood pressure in women and 
men. 
Methods: Paper I is a review based on “Moderately elevated blood pressure, a systematic literature 
review” by the Swedish Council on Technology Assessment in Health Care (SBU). Paper I analyses 
the proportion of women included and gender specific data on blood pressure reduction and outcome. 
Paper II is a retrospective study carried out in primary health care including patients with newly 
diagnosed hypertension, investigating blood pressure levels, antihypertensive treatment and time to 
satisfying blood pressure control in women and men. Paper III and IV are retrospective cohort studies 
carried out in the Swedish Primary Care Cardiovascular Database (SPCCD) including patients with 
ongoing hypertension. These studies investigate blood pressure levels, achieved target blood pressure, 
antihypertensive treatment, comorbidities and psychosocial factors in women and men with 
hypertension. 
Results: In Paper I, two studies (VALUE and ALLHAT) showed a better blood pressure reduction 
with calcium channel blockers compared to angiotensin receptor blocker (ARB) and angiotensin 
converting enzyme inhibitor (ACEI) and this was more pronounced in women. In ALLHAT the 
calcium channel blocker was superior to both the diuretic and ACEI in reducing stroke incidence in 
women but not in men. In VALUE, calcium channel blocker-based therapy was superior to the ARB-
based therapy in reducing the composite endpoint of cardiac morbidity and mortality in women but 
not in men (p<0.05). In Paper II, 332 male and 334 female patients were included. There was no 
gender difference in systolic blood pressure (SBP) before and after treatment. Women had a lower 
diastolic blood pressure (DBP) before and after intervention. There was no difference between the 
proportion of women and men reaching the predefined goal of treatment. In Paper III and IV, 40 825 
patients with current hypertension were included. In patients older than 69 years, women had a higher 
SBP, except in patients of 90 years of age or older. Achieved DBP dropped with age in both genders 
and was lower in women in all age groups except in patients 90 years or older. Achieved SBP was 
higher in women in all subgroups of comorbidities except in patients with asthma. Fewer women than 
men reached target blood pressure (p<0.0001). Women were more often prescribed thiazide diuretics, 
loop diuretics and beta receptor blockers and men were more often prescribed ACEI, and this was 
consistent also after adjusting for age, comorbidities and smoking. The predominant use of ACEI and 
calcium channel blockers in men was not influenced by education, country of birth and psychiatric 
disorder. However, in well-educated patients women were not prescribed diuretics and beta receptor 
blockers more often than men. In women, education and psychiatric disorder was associated with 
reaching target blood pressure. 
Conclusion: Women and men are treated with different antihypertensive drugs and this is not fully 
explained by differences in comorbidities. Women with diabetes mellitus are not treated with ACEI or 
ARB to the same extent as their male counterparts. Women with hypertension reach target blood 
pressure less often than men and women have a higher achieved SBP in all subgroups of concomitant 
cardiovascular disease. Higher educational level and psychiatric disorder are associated with reaching 
target blood pressure in women. Efforts should be made to emphasize the risk evaluation in women 
with hypertension and concomitant cardiovascular disease to improve blood pressure control. 
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